Iliad and Novartis Executives Discuss Biopharma Alliance Strategy
What happened
Executives from Iliad and Novartis joined a panel discussion on November 21, 2026, regarding biopharma alliances. Laura Vasquez moderated the event, where speakers discussed how strategic partnerships are built gradually through relationship-building over months or years, rather than stemming from a single pitch or data readout. The discussion also covered how companies should ask partners what evidence they require before proposing formal business deals.
From bioxconomy.com
Why it matters
The discussion highlights the long-term, relationship-driven nature of strategic partnerships within the biopharma industry. This perspective suggests that the formation of major industry alliances relies on sustained trust and gradual relationship development.
From bioxconomy.com